Home » Clinical Trials » Search Clinical Trials Therapeutic Areas: Oncology | Dermatology | Family Medicine
Metastatic Melanoma Clinical Trials
A listing of Metastatic Melanoma medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
First 1 2 3 4 5 6 7 8 9 10 Last
Alabama
GSK Investigational Site
A Phase 3 clinical study for patients with Melanoma
Birmingham Alabama 35233Updated
Patients are needed to participate in a clinical research study of vemurafenib, Placebo and GDC-0973 (cobimetinib) to evaluate Malignant Melanoma
Arizona
GSK Investigational Site
A Phase 3 clinical study for patients with Melanoma
Mayo Clinic Arizona - Cancer Clinical Research Unit
Updated
Patients are needed to participate in a clinical research study evaluating CDX-1127
Call for Information (Investigational Site 0004)
Updated
Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor
The University of Arizona Cancer Center
A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma
California
Call for Information (Investigational Site 0027)
Updated
Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor
Call for Information (Investigational Site 0030)
Updated
Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor
Call for Information (Investigational Site 0135)
Updated
Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor
Moores UCSD Cancer Center
A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma
View More »
Moores UCSD Cancer Center
Updated
A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma
La Jolla California 92037Updated
Patients are needed to participate in a clinical research study of vemurafenib, Placebo and GDC-0973 (cobimetinib) to evaluate Malignant Melanoma
USC Norris Cancer Center
A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma
Los Angeles California
A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma
Call for Information (Investigational Site 0015)
Updated
Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor
Call for Information (Investigational Site 0010)
Updated
Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor
Los Angeles California 90025Updated
Patients are needed to participate in a clinical research study of vemurafenib, Placebo and GDC-0973 (cobimetinib) to evaluate Malignant Melanoma
Los Angeles California 90095Updated
Patients are needed to participate in a clinical research study of vemurafenib, Placebo and GDC-0973 (cobimetinib) to evaluate Malignant Melanoma
Pleasant Hill California 94523Updated
Patients are needed to participate in a clinical research study of vemurafenib, Placebo and GDC-0973 (cobimetinib) to evaluate Malignant Melanoma
Sacramento California 95817Updated
Patients are needed to participate in a clinical research study of vemurafenib, Placebo and GDC-0973 (cobimetinib) to evaluate Malignant Melanoma
Call for Information (Investigational Site 0008)
Updated
Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor
Santa Rosa California 95403Updated
Patients are needed to participate in a clinical research study of vemurafenib, Placebo and GDC-0973 (cobimetinib) to evaluate Malignant Melanoma
Stanford Cancer Center - Stanford University
Updated
Patients are needed to participate in a clinical research study evaluating CDX-1127
GSK Investigational Site
A Phase 3 clinical study for patients with Melanoma
Vallejo California 94589Updated
Patients are needed to participate in a clinical research study of vemurafenib, Placebo and GDC-0973 (cobimetinib) to evaluate Malignant Melanoma
Colorado
University of Colorado Cancer Center
A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma
GSK Investigational Site
A Phase 3 clinical study for patients with Melanoma
Aurora Colorado 80045Updated
Patients are needed to participate in a clinical research study of vemurafenib, Placebo and GDC-0973 (cobimetinib) to evaluate Malignant Melanoma
Connecticut
Hartford Connecticut 06102Updated
Patients are needed to participate in a clinical research study of vemurafenib, Placebo and GDC-0973 (cobimetinib) to evaluate Malignant Melanoma
Smilow Cancer Hospital at Yale New Haven
A clinical trial to evaluate treatments using Vemurafenib for patients with Melanoma [C04.557.465.625.650.510]
Call for information (site 0028)
Updated
Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor
District of Columbia
Washington Cancer Institute at MedStar Washington Hospital Center
Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma
Georgetown University Medical Center
Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma
Florida
View More »
Fort Myers Florida 33901Updated
Patients are needed to participate in a clinical research study of vemurafenib, Placebo and GDC-0973 (cobimetinib) to evaluate Malignant Melanoma
GSK Investigational Site
A Phase 3 clinical study for patients with Melanoma
Call for Information (Investigational Site 0003)
Updated
Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor
Mount Sinai Medical Center Comprehensive Cancer Center
A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma
MSMC Research Program
Updated
A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma
Miami Beach Florida 33140Updated
Patients are needed to participate in a clinical research study of vemurafenib, Placebo and GDC-0973 (cobimetinib) to evaluate Malignant Melanoma
GSK Investigational Site
A Phase 3 clinical study for patients with Melanoma
Orlando Florida 32806Updated
Patients are needed to participate in a clinical research study of vemurafenib, Placebo and GDC-0973 (cobimetinib) to evaluate Malignant Melanoma
H. Lee Moffitt Cancer Center and Research Institute
A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma
Tampa Florida
A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma
Call for Information (Investigational Site 0018)
Updated
Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor
H. Lee Moffitt Cancer Center and Research Institute
Patients are needed to participate in a clinical research study for the treatment of Metastatic Melanoma
Georgia
Memorial University Medical Center
Alliance/NCCTG N0879: A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
View More »
Emory University Winship Cancer Institute
A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma
First 1 2 3 4 5 6 7 8 9 10 Last
